fda halts glp-1 Cheaper Versions: Clinical Implications – PlexusDx GLP-1 Medications – FDA Guidance

Slow titration is the most important variable

These drugs, known as GLP-1 receptor agonists, have ushered in a new era of treatment options that are changing lives and reshaping our approach to weight management and metabolic health

He says it's seen as a "disease of choice, where people are eating too much and not trying hard enough and don't have enough willpower." But when his patients see how much the medication helps them if diets and excercise don't work, he says they often realize the issue is a medical one not a personal failing

This creates a unique metabolic dance that the body needs time to adjust to, which is why the retatrutide dose schedule uses a gradual titration over many weeks